News Room

RSS

News Room provides integrated information to the media. In some instances, information on products or drug candidates under development may be included, but this is intended for members of the media, shareholders, and investors. The information is not intended for promotional or advertising purposes, or as medical advice, etc.

The Latest Media Conference

Chugai Information Meeting on Gene Therapy for Duchenne Muscular Dystrophy

Presentations:

Overview of Elevidys for Intravenous Infusion
Yoko Sano, Elevidys Lifecycle Leader, Chugai Pharmaceutical Co., Ltd.
Duchenne Muscular Dystrophy (DMD): Disease and Treatment, Clinical Framework for Gene Therapy, Appropriate Use, and Clinical Positioning
Hirofumi Komaki, M.D., Ph.D., Director, Translational Medical Center National Center Hospital, National Center of Neurology and Psychiatry

News

01

Topics about Advanced and sustainable patient-centric healthcare

We introduce Chugai's initiatives for "Patient-Centric," which we uphold as our highest priority "Core Value.

  • #Patient-Centricity
  • #Science and Technology
  • #Digital Technology

Creating New Forms of Patient Contribution Through Real‑World Data: How the Drug Safety Division Is Leading the Way

Chugai Pharmaceutical is promoting the company-wide use of real-world data (RWD)*¹. In this article, we focus in particular on project members from the Dr

  • R&D
  • DX
  • Sustainable Healthcare
  • #Patient-Centricity
  • #Science and Technology
  • #Sustainability

Innovating Pharmaceutical Packaging to Protect Patients and the Planet: Chugai's Challenge to Implement Recycled Plastics and Biomass-Based Materials

Pharmaceutical packaging is far more than a simple container. It serves a vital mission: safeguarding drug quality, supporting improved usability for patients,

  • R&D
  • Sustainability
  • Sustainable Healthcare
  • Global Environment
  • #Patient-Centricity
  • #Science and Technology
  • #Co-Creation

"Creating Drugs That Benefit the World": A Century of Purpose and the Future Chugai Is Building

On March 10, 2025, Chugai Pharmaceutical celebrated its 100th anniversary. To commemorate this milestone, we held a Commemorative Ceremony in May 2025, welcomi

  • Innovation
  • Sustainable Healthcare
  • 100th Anniversary
  • #Patient-Centricity
  • #Digital Technology
  • #Co-Creation

Carrying Patient Voices Into the Future: Japan’s Bleeding Disorders Registry

Delivering optimal care even for rare diseases — driven by this commitment, patient advocacy groups, an academic society, and a pharmaceutical company jo

  • Disease Awareness
  • Sustainable Healthcare
  • #Sustainability
  • #Co-Creation

Learning Through Play: Cutting-Edge Drug Discovery at EXPO 2025. Chugai Employees Take On the Challenge of "Designing Future Society for Our Lives" at the Osaka-Kansai World Expo

"I defeated the cancer cells!" "Making medicine seems tough, but it's so cool!" The event venue was bustling with families, and children's excited voices echoe

  • Sustainability
  • Sustainable Healthcare
  • Social Contribution
  • Event
  • #Patient-Centricity

Transforming Healthcare: Enhancing Sales Capabilities to Deliver Optimal Treatment to Patients

Chugai Pharmaceutical launched the Medical Partner for the Patient (MPP) program ahead of its competitors to establish an industry-leading consulting team that

  • Recruitment
  • Sustainable Healthcare
  • Medical Representative
  • Sales
  • #Patient-Centricity
  • #Sustainability
  • #Co-Creation

Working with Patients to Create a Future in Which Every Person Can Choose the Optimal Form of Treatment

Patients are at the center of all Chugai Pharmaceutical’s corporate activities, and the company is in constant pursuit of value to benefit them. Takeuchi

  • Recruitment
  • Sustainable Healthcare
  • Corporate
  • PHARMONY

The 6th Workshop on Multidisciplinary Team Care for Healthcare Professionals in Cambodia ～Co‐Creation Zoo: Artistic Approach to Team Building Workshop～

  • Advanced and sustainable patient-centric healthcare
  • Global Health
  • Social Contribution

Supporting the Cervical Cancer Elimination Program in Marshall Islands and Fiji

  • Advanced and sustainable patient-centric healthcare
  • Global Health
  • Social Contribution

Support for improving access to health care in remote villages in Nepal

  • Advanced and sustainable patient-centric healthcare
  • Global Health
  • Social Contribution

Support for a remote ophthalmology screening project in Cambodia 2025

  • Advanced and sustainable patient-centric healthcare
  • Global Health
  • Social Contribution

Elimination of cervical cancer and related morbidity and mortality in the context of Universal Health Coverage in Bhutan

  • Advanced and sustainable patient-centric healthcare
  • Global Health
  • Social Contribution

Supporting the Cervical Cancer Elimination Program in Marshall Islands and Fiji

  • Advanced and sustainable patient-centric healthcare
  • Global Health
  • Social Contribution

Elimination of cervical cancer and related morbidity and mortality in the context of Universal Health Coverage in Bhutan

  • Advanced and sustainable patient-centric healthcare
  • Global Health
  • Social Contribution

The 5th Workshop on Multidisciplinary Team Care for Healthcare Professionals in Cambodia

  • Advanced and sustainable patient-centric healthcare
  • Global Health
  • Social Contribution
02

Topics about Innovation

Every employee is committed to pursuing innovation that only we can do to realize "advanced and sustainable patient-centric healthcare"

  • #Patient-Centricity
  • #Science and Technology
  • #Co-Creation

"Creating Drugs That Benefit the World": A Century of Purpose and the Future Chugai Is Building

On March 10, 2025, Chugai Pharmaceutical celebrated its 100th anniversary. To commemorate this milestone, we held a Commemorative Ceremony in May 2025, welcomi

  • Innovation
  • Sustainable Healthcare
  • 100th Anniversary
  • #Science and Technology
  • #Open Innovation

“CHUGAI INNOVATION DAY 2025” Event Report

The business conference "CHUGAI INNOVATION DAY 2025" hosted by Chugai Pharmaceutical was held at Marunouchi Building Hall & Conference Square (Marunouchi,

  • Innovation
  • R&D
  • DX
  • Partnering
  • Event
  • 100th Anniversary
  • #Co-Creation

Passing the Baton of Passion: The "My Action Declaration" 100th Anniversary Project

On March 10, 2025, Chugai Pharmaceutical celebrated its 100th anniversary. As part of this historic milestone, the company launched "My Action Declaration," an

  • Innovation
  • #Science and Technology
  • #Open Innovation

Creating and Expanding Regulatory T cells: The Possibility of Cellular Therapy Explored by a Joint Research Team from Chugai and the Immunology Frontier Research Center (IFReC), the University of Osaka

The immune system protects the body from harm. In this process, regulatory T cells act as regulators or brakes suppressing excessive immune responses. A recent

  • Innovation
  • R&D
  • #Science and Technology
  • #Co-Creation

Engraving the Memory of Life Science: Monuments at Chugai Life Science Park Yokohama Earn Global Design Honors

Nestled in the lush greenery of Totsuka, Yokohama, Chugai Pharmaceutical’s Research Laboratory, Chugai Life Science Park Yokohama, now welcomes visitors

  • Innovation
  • R&D
  • #Patient-Centricity
  • #Science and Technology
  • #Digital Technology

Transforming Bioprocesses Through the Use of AI: A Challenge Driven by Collaboration Between Data Scientists and Bioprocess Researchers

Bioprocessing is a method of producing active pharmaceutical ingredients for biopharmaceuticals using living cells and microorganisms, and it plays a criticall

  • Innovation
  • R&D
  • DX
  • #Digital Technology
  • #Open Innovation
  • #Co-Creation

CHUGAI INNOVATION DAY 2024 Report—More Than 3,000 in Attendance

Chugai Pharmaceutical’s CHUGAI INNOVATION DAY 2024 was hosted on November 25 (Mon) and 26 (Tue), 2024. This was the fifth hosting of the CHUGAI INNOVATIO

  • Innovation
  • R&D
  • DX
  • Event
  • #Science and Technology

Working to Reform the Drug Discovery Process—Acceleration of Drug Discovery Research Using Cryo-EM

Torizawa is general manager of the Protein Science Research Department. He is currently in charge of the early stages of drug discovery to uncover molecules th

  • Innovation
  • R&D
  • Recruitment
  • Research
  • Cryo-Electron Microscopy
03

Topics about Sustainability

We will introduce our latest activities aimed at solving social issues through our business operations, in pursuit of "creating shared value" with society.

Support for Children’s Performance of “Momotaro:”

  • Social Contribution
  • Society
  • Next Generation Development

Support for Children’s Performance of “The Three Little Pigs”

  • Social Contribution
  • Society
  • Next Generation Development

Roche Children’s Walk 2018

  • Social Contribution
  • Society

Charity Sale to Support the Great East Japan Earthquake and the 2016 Kumamoto Earthquake

  • Social Contribution
  • Society

Exhibiting at the Nihonbashi Kid’s Town! 2018 “Experience Real Jobs” Event

  • Social Contribution
  • Society
  • Next Generation Development

Participating in the 48th Annual Cleaning of the Famed Nihonbashi Bridge

  • Social Contribution
  • Society

Biology Lab Classes for Children Held (2018)

  • Social Contribution
  • Next Generation Development

2018 Private Sector Training for Teachers Held

  • Social Contribution
  • Next Generation Development
04

Pickup Contents

Features of the Strategic Alliance and Business Model “Alliance with Roche”

Features of the Strategic Alliance and Business Model “Transactions with Roche”

Press Room

Resources for the Media including press releases, presentation slides, videos and other materials are available.

Features of the Strategic Alliance and Business Model “Alliance with Roche”（7:04）

Features of the Strategic Alliance and Business Model “Alliance with Roche”

In 2002, Chugai started a strategic alliance with the Swiss company Roche, one of the world’s leading pharmaceutical companies. Under its unique business model, Chugai has realized its continuous growth.

While a member of the Roche Group, Chugai maintains its autonomous management and listing on the Tokyo Stock Exchange, enabling Chugai to focus on innovation with an emphasis on originality. This unprecedented business model contributes to enhancing Chugai’s corporate value and developing the Roche Group.

In this video, we will show the strategic alliance with Roche that forms the basis for this unique business model.

Features of the Strategic Alliance and Business Model “Transactions with Roche”（12:43）

Features of the Strategic Alliance and Business Model “Transactions with Roche”

In 2002, Chugai started a strategic alliance with the Swiss company Roche, one of the world’s leading pharmaceutical companies.
Under its unique business model, Chugai has realized its continuous growth.

In this video, we will present the financial impact that transactions with Roche under the strategic alliance have on Chugai.
The explanation will be divided into two parts: “out-licensing of in-house products to Roche” and “in-licensing of products from Roche.”

View in Japanese